Markus Schirle Selected Research

Markus Schirle Research Topics

Disease

15	Neoplasms (Cancer) 10/2022 - 10/2002
2	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2019
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Skin Ulcer 01/2021
1	Leukemia 01/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019
1	Hypersensitivity (Allergy) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Infections 11/2015
1	Malaria 11/2015
1	Starvation 11/2014
1	Intellectual Disability (Idiocy) 10/2014
1	Multiple Myeloma 08/2014
1	Staphylococcal Infections 11/2013
1	Hepatitis C 02/2010
1	Inflammation (Inflammations) 10/2008
1	Necrosis 02/2004
1	Pathologic Processes 02/2004
1	Melanoma (Melanoma, Malignant) 05/2002

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2002
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2020 - 10/2014
2	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 01/2020
2	nimbolideIBA 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2004
2	Biological ProductsIBA 01/2019 - 01/2019
2	LigandsIBA 12/2002 - 10/2002
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2002 - 10/2002
1	Adenosine Triphosphatases (ATPase)IBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Annexin A5IBA 10/2022
1	Chloride Channels (Chloride Channel)IBA 01/2022
1	lumacaftorIBA 01/2022
1	manumycinIBA 11/2020
1	PolyketidesIBA 11/2020
1	JTE 607IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	snake venom protein C activatorIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	Complement C5 (Complement 5)IBA 01/2019
1	Bromodomain Containing ProteinsIBA 01/2019
1	eculizumab FDA Link 01/2019
1	Terpenes (Terpenoids)IBA 01/2019
1	LignansIBA 01/2019
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	TankyrasesIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	AngiomotinsIBA 01/2016
1	Peptide Elongation Factor 1 (EF-1)IBA 08/2015
1	Ferritins (Ferritin)IBA 11/2014
1	IronIBA 11/2014
1	Thalidomide (Thalomid)FDA Link 08/2014
1	pomalidomideIBA 08/2014
1	Lenalidomide (CC 5013)FDA Link 08/2014
1	Immunomodulating AgentsIBA 08/2014
1	OSW 1IBA 08/2011
1	Carrier Proteins (Binding Protein)IBA 08/2011
1	cephalostatin IIBA 08/2011
1	schweinfurthin AIBA 08/2011
1	oxysterol binding proteinIBA 08/2011
1	ritterazine BIBA 08/2011
1	OxysterolsIBA 08/2011
1	CateninsIBA 05/2011
1	(melle-4)cyclosporinIBA 02/2010
1	Cyclophilins (Cyclophilin)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	NF-kappa B (NF-kB)IBA 02/2004
1	CytokinesIBA 02/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2004
1	AntigensIBA 05/2002
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2002
1	HLA-A*02:01 antigenIBA 05/2002
1	EpitopesIBA 05/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2002

Therapy/Procedure

6	Therapeutics 10/2022 - 10/2009